Pro-Arc Diagnostics

Origin: MO | Grant Awarded: 2016 | Status: Exited

What is Pro-Arc Diagnostics?

Pro-Arc Diagnostics is a developing next-generation laboratory test for patients at risk of Progressive Multifocal Leukoencephalopathy (PML). PML is caused by the John Cunningham Virus and is responsible for thousands of deaths each year. To date, doctors have had no way to determine which patients were at risk for developing PML. Pro-Arc’s technology is being designed to identify these patients, which may eventually allow doctors to monitor PML risk and safely design treatment courses in response.

Company Leadership

Michelle Faits

Co-Founder and Chief Executive Officer

Michelle is a Ph.D. scientist and a 2016 Pipeline Fellow and Associate Entrepreneur with the BioSTL Fundamentals program.

Connect on LinkedIn →

Dana Watt

Co-Founder and Chief Scientific Officer

Dana is a Ph.D. scientist and a Postdoctoral Fellow in Accelerated Innovation at the Skandalaris Center at Washington University in St. Louis.

Connect on LinkedIn →

James Sorrell

Co-Founder and Chief Financial Officer

James has a background as a Venture Analyst at the Skandalaris Center, and is the former IT Director and Consultant with the BALSA Group.

Connect on LinkedIn →

Chris Bethel

Advisor

Chris bring over 10 years of experience developing highly sensitive analytical methods in regulated environments to the Pro-Arc team, including extensive technical expertise in the analytical technique which the Pro-Arc’s tech is built upon.

Connect on LinkedIn →

Involved Industries

Be a Part of the Movement

We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.